Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of postsynapse	MPP2 POTEF NEFH POTEE POTEI POTEJ	9.78e-09	32	98	6	GO:0099186
GeneOntologyMolecularFunction	structural constituent of synapse	MPP2 POTEF NEFH POTEE POTEI POTEJ	5.44e-08	42	98	6	GO:0098918
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEF POTEE POTEI POTEJ	1.75e-07	11	98	4	GO:0098973
GeneOntologyMolecularFunction	RNA-dependent RNA polymerase activity	POLR2A TERT	7.13e-05	3	98	2	GO:0003968
GeneOntologyMolecularFunction	phosphoric diester hydrolase activity	ENPP7 PDE1B PLCB1 PLD6 PLCB3	1.16e-04	97	98	5	GO:0008081
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	ENPP7 PTPMT1 PDE1B PTPRD PTPRO PTPRS PLCB1 PLD6 PLCB3	1.19e-04	386	98	9	GO:0042578
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	POTEF NEFH POTEE POTEI POTEJ	4.53e-04	130	98	5	GO:0005200
GeneOntologyMolecularFunction	telomerase activity	TERF2 TERT	4.93e-04	7	98	2	GO:0003720
GeneOntologyMolecularFunction	kinase binding	POTEF POLR2A LDHA LIN7B NEFH POTEE TFPT CDK5RAP1 POTEI POTEJ FRMD5 TP53 HSP90AB1	8.95e-04	969	98	13	GO:0019900
GeneOntologyBiologicalProcess	postsynaptic cytoskeleton organization	POTEF NEFH POTEE POTEI POTEJ	6.02e-07	35	97	5	GO:0099188
GeneOntologyBiologicalProcess	postsynaptic actin cytoskeleton organization	POTEF POTEE POTEI POTEJ	1.31e-05	31	97	4	GO:0098974
GeneOntologyBiologicalProcess	postsynapse organization	POTEF CKAP5 NEFH POTEE PTPRD PTPRS POTEI POTEJ EPHB1	1.69e-05	313	97	9	GO:0099173
GeneOntologyBiologicalProcess	RNA-templated transcription	POLR2A TERT	6.55e-05	3	97	2	GO:0001172
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	POTEF POTEE POTEI POTEJ	1.48e-05	32	98	4	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	POTEF POTEE POTEI POTEJ	1.48e-05	32	98	4	GO:0043189
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	POTEF POTEE POTEI POTEJ	5.84e-05	45	98	4	GO:1902562
GeneOntologyCellularComponent	histone acetyltransferase complex	POTEF POTEE TADA2A POTEI POTEJ	8.06e-05	94	98	5	GO:0000123
GeneOntologyCellularComponent	protein acetyltransferase complex	POTEF POTEE TADA2A POTEI POTEJ	1.30e-04	104	98	5	GO:0031248
GeneOntologyCellularComponent	acetyltransferase complex	POTEF POTEE TADA2A POTEI POTEJ	1.62e-04	109	98	5	GO:1902493
GeneOntologyCellularComponent	actin filament	POTEF POTEE TFPT POTEI POTEJ	6.26e-04	146	98	5	GO:0005884
GeneOntologyCellularComponent	neuron to neuron synapse	MPP2 RPL14 BCR LIN7B NEFH PTPRD AKAP9 PTPRO PTPRS	7.85e-04	523	98	9	GO:0098984
GeneOntologyCellularComponent	Schaffer collateral - CA1 synapse	MPP2 BCR NEFH PTPRD PTPRS	8.20e-04	155	98	5	GO:0098685
GeneOntologyCellularComponent	postsynaptic density membrane	MPP2 LIN7B AKAP9 PTPRO PTPRS	8.68e-04	157	98	5	GO:0098839
GeneOntologyCellularComponent	axon	POTEF BCR TERF2 NEFH POTEE ARHGAP4 PTPRO PTPRS POTEI POTEJ HSP90AB1 EPHB1	9.34e-04	891	98	12	GO:0030424
GeneOntologyCellularComponent	postsynaptic density	MPP2 RPL14 BCR LIN7B NEFH AKAP9 PTPRO PTPRS	1.28e-03	451	98	8	GO:0014069
GeneOntologyCellularComponent	nuclear telomere cap complex	TERF2 TERT	1.64e-03	13	98	2	GO:0000783
GeneOntologyCellularComponent	telomere cap complex	TERF2 TERT	1.64e-03	13	98	2	GO:0000782
GeneOntologyCellularComponent	asymmetric synapse	MPP2 RPL14 BCR LIN7B NEFH AKAP9 PTPRO PTPRS	1.82e-03	477	98	8	GO:0032279
GeneOntologyCellularComponent	nuclear protein-containing complex	POLR2A INTS1 WDR83 GEMIN5 TERF2 TERT TFPT DDX46 NFE2 TXNL4B CTNNBL1 MPHOSPH6 CDC27 TP53 HSP90AB1	1.83e-03	1377	98	15	GO:0140513
GeneOntologyCellularComponent	chromosome, telomeric repeat region	TERF2 TERT	1.91e-03	14	98	2	GO:0140445
GeneOntologyCellularComponent	Prp19 complex	POLR2A CTNNBL1	2.50e-03	16	98	2	GO:0000974
GeneOntologyCellularComponent	postsynaptic specialization	MPP2 RPL14 BCR LIN7B NEFH AKAP9 PTPRO PTPRS	2.52e-03	503	98	8	GO:0099572
GeneOntologyCellularComponent	postsynaptic specialization membrane	MPP2 LIN7B AKAP9 PTPRO PTPRS	2.58e-03	201	98	5	GO:0099634
GeneOntologyCellularComponent	postsynapse	MPP2 NAPA RPL14 BCR LIN7B NEFH AKAP9 PTPRO PTPRS PLCB1 FGF7 PLCB3	2.86e-03	1018	98	12	GO:0098794
Domain	Actin_CS	POTEF ACTR1B POTEE POTEI POTEJ	1.28e-08	16	95	5	IPR004001
Domain	ACTINS_2	POTEF ACTR1B POTEE POTEI POTEJ	1.80e-08	17	95	5	PS00432
Domain	Actin/actin-like_CS	POTEF ACTR1B POTEE POTEI POTEJ	2.49e-08	18	95	5	IPR020902
Domain	ACTINS_ACT_LIKE	POTEF ACTR1B POTEE POTEI POTEJ	3.36e-08	19	95	5	PS01132
Domain	Actin	POTEF ACTR1B POTEE POTEI POTEJ	4.68e-07	31	95	5	IPR004000
Domain	Actin	POTEF ACTR1B POTEE POTEI POTEJ	4.68e-07	31	95	5	PF00022
Domain	ACTIN	POTEF ACTR1B POTEE POTEI POTEJ	4.68e-07	31	95	5	SM00268
Domain	fn3	IGFN1 MYOM3 OBSL1 PTPRD PTPRO PTPRS EPHB1	1.89e-05	162	95	7	PF00041
Domain	Aquaporin_12	AQP12A AQP12B	2.56e-05	2	95	2	IPR023265
Domain	FN3	IGFN1 MYOM3 OBSL1 PTPRD PTPRO PTPRS EPHB1	4.43e-05	185	95	7	SM00060
Domain	FN3	IGFN1 MYOM3 OBSL1 PTPRD PTPRO PTPRS EPHB1	7.02e-05	199	95	7	PS50853
Domain	PLC-beta_C	PLCB1 PLCB3	7.65e-05	3	95	2	IPR014815
Domain	PLC-beta_CS	PLCB1 PLCB3	7.65e-05	3	95	2	IPR009535
Domain	Aquaporin_11/12	AQP12A AQP12B	7.65e-05	3	95	2	IPR016697
Domain	DUF1154	PLCB1 PLCB3	7.65e-05	3	95	2	PF06631
Domain	PLC-beta_C	PLCB1 PLCB3	7.65e-05	3	95	2	PF08703
Domain	FN3_dom	IGFN1 MYOM3 OBSL1 PTPRD PTPRO PTPRS EPHB1	9.55e-05	209	95	7	IPR003961
Domain	PLC-beta	PLCB1 PLCB3	1.53e-04	4	95	2	IPR016280
Domain	Tyr_Pase_AS	PTPMT1 PTPRD PTPRO PTPRS	5.23e-04	73	95	4	IPR016130
Domain	PTPc	PTPRD PTPRO PTPRS	8.06e-04	36	95	3	SM00194
Domain	TYR_PHOSPHATASE_1	PTPMT1 PTPRD PTPRO PTPRS	9.70e-04	86	95	4	PS00383
Domain	TYR_PHOSPHATASE_2	PTPMT1 PTPRD PTPRO PTPRS	1.01e-03	87	95	4	PS50056
Domain	TYR_PHOSPHATASE_dom	PTPMT1 PTPRD PTPRO PTPRS	1.01e-03	87	95	4	IPR000387
Domain	TYR_PHOSPHATASE_PTP	PTPRD PTPRO PTPRS	1.02e-03	39	95	3	PS50055
Domain	L27_C	MPP2 LIN7B	1.12e-03	10	95	2	IPR014775
Domain	Phosphodiest	ENPP7 PIGO	1.12e-03	10	95	2	PF01663
Domain	L27	MPP2 LIN7B	1.12e-03	10	95	2	PF02828
Domain	Phosphodiest/P_Trfase	ENPP7 PIGO	1.12e-03	10	95	2	IPR002591
Domain	PTPase_domain	PTPRD PTPRO PTPRS	1.18e-03	41	95	3	IPR000242
Domain	Y_phosphatase	PTPRD PTPRO PTPRS	1.18e-03	41	95	3	PF00102
Domain	-	PTPMT1 PTPRD PTPRO PTPRS	1.25e-03	92	95	4	3.90.190.10
Domain	PNMA	MOAP1 PNMA3	1.37e-03	11	95	2	PF14893
Domain	PNMA	MOAP1 PNMA3	1.37e-03	11	95	2	IPR026523
Domain	PX	SNX17 SNX13 SNX12	1.45e-03	44	95	3	SM00312
Domain	Prot-tyrosine_phosphatase-like	PTPMT1 PTPRD PTPRO PTPRS	1.63e-03	99	95	4	IPR029021
Domain	ANK_REPEAT	POTEF MUC16 YTHDC2 POTEE POTEI POTEJ	1.85e-03	253	95	6	PS50088
Domain	ANK_REP_REGION	POTEF MUC16 YTHDC2 POTEE POTEI POTEJ	1.89e-03	254	95	6	PS50297
Domain	L27	MPP2 LIN7B	1.93e-03	13	95	2	SM00569
Domain	L27	MPP2 LIN7B	1.93e-03	13	95	2	PS51022
Domain	L27_dom	MPP2 LIN7B	1.93e-03	13	95	2	IPR004172
Domain	PX	SNX17 SNX13 SNX12	1.98e-03	49	95	3	PF00787
Domain	PX	SNX17 SNX13 SNX12	2.10e-03	50	95	3	PS50195
Domain	-	EFCAB5 CABP2 RYR1 EFCAB12 PLCB1 PLCB3	2.17e-03	261	95	6	1.10.238.10
Domain	-	SNX17 SNX13 SNX12	2.22e-03	51	95	3	3.30.1520.10
Domain	MIP	AQP12A AQP12B	2.24e-03	14	95	2	PS00221
Domain	MIP	AQP12A AQP12B	2.24e-03	14	95	2	PF00230
Domain	Phox	SNX17 SNX13 SNX12	2.35e-03	52	95	3	IPR001683
Domain	MIP	AQP12A AQP12B	2.57e-03	15	95	2	IPR000425
Domain	PLipase_C_Pinositol-sp_Y	PLCB1 PLCB3	2.57e-03	15	95	2	IPR001711
Domain	EF-hand_like	PLCB1 PLCB3	2.57e-03	15	95	2	PF09279
Domain	PIPLC_Y_DOMAIN	PLCB1 PLCB3	2.57e-03	15	95	2	PS50008
Domain	-	AQP12A AQP12B	2.57e-03	15	95	2	1.20.1080.10
Domain	PI-PLC_fam	PLCB1 PLCB3	2.57e-03	15	95	2	IPR001192
Domain	PLC_EF-hand-like	PLCB1 PLCB3	2.57e-03	15	95	2	IPR015359
Domain	PI-PLC-Y	PLCB1 PLCB3	2.57e-03	15	95	2	PF00387
Domain	PLCYc	PLCB1 PLCB3	2.57e-03	15	95	2	SM00149
Domain	Aquaporin-like	AQP12A AQP12B	2.57e-03	15	95	2	IPR023271
Domain	Ig_I-set	IGFN1 MYOM3 OBSL1 PTPRD PTPRS	2.86e-03	190	95	5	IPR013098
Domain	I-set	IGFN1 MYOM3 OBSL1 PTPRD PTPRS	2.86e-03	190	95	5	PF07679
Domain	PTPc_motif	PTPRD PTPRO PTPRS	3.37e-03	59	95	3	SM00404
Domain	Tyr_Pase_cat	PTPRD PTPRO PTPRS	3.37e-03	59	95	3	IPR003595
Domain	EF-hand-dom_pair	EFCAB5 CABP2 RYR1 EFCAB12 PLCB1 PLCB3	3.46e-03	287	95	6	IPR011992
Domain	PI-PLC-X	PLCB1 PLCB3	3.71e-03	18	95	2	PF00388
Domain	PLCXc	PLCB1 PLCB3	3.71e-03	18	95	2	SM00148
Domain	PIPLC_X_DOMAIN	PLCB1 PLCB3	4.14e-03	19	95	2	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCB1 PLCB3	4.14e-03	19	95	2	IPR000909
Domain	C2	WWP2 BCR PLCB1 PLCB3	4.50e-03	131	95	4	PF00168
Domain	Apc4_WD40_dom	GEMIN5 WRAP73	4.58e-03	20	95	2	IPR024977
Domain	ANAPC4_WD40	GEMIN5 WRAP73	4.58e-03	20	95	2	PF12894
Pubmed	Evolution and expression of chimeric POTE-actin genes in the human genome.	POTEF POTEE POTEJ	2.17e-08	3	98	3	17101985
Pubmed	Defining the membrane proteome of NK cells.	DOCK2 GALK1 WWP2 INTS1 CKAP5 NAPA GEMIN5 DDX56 RPL14 LDHA BCR COG8 ACTR1B CTNNBL1 STAMBPL1 PIGO HSP90AB1	2.76e-08	1168	98	17	19946888
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEF POTEE POTEI POTEJ	7.90e-08	15	98	4	16824795
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	GALK1 NET1 FAT3 POLR2A OBSL1 DDX56 YTHDC2 MAST2 BCR ARHGAP4 TFPT WRAP73 CTNNBL1 TADA2A CDC27 TP53	9.12e-08	1116	98	16	31753913
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	INTS1 CKAP5 NAPA GEMIN5 LDHA TERF2 DDX46 LMO7 WASHC5	5.38e-07	340	98	9	24332808
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	GALK1 WWP2 OBSL1 WDR83 NAPA DDX56 RPL14 LDHA GRSF1 DDX46 AKAP9 LMO7 CTNNBL1 POTEJ TP53 HSP90AB1	1.40e-06	1371	98	16	36244648
Pubmed	CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.	POTEF RPL14 LDHA POTEE POTEI POTEJ TP53 HSP90AB1	1.66e-06	288	98	8	31501420
Pubmed	Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.	POTEE POTEI POTEJ	1.80e-06	9	98	3	16364570
Pubmed	The physical map of Mus musculus chromosome 11 reveals evolutionary relationships with different syntenic groups of genes in Homo sapiens.	GALK1 POLR2A TP53	3.52e-06	11	98	3	3116273
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MPP2 INTS1 RPL14 LDHA MAST2 TERF2 ACTR1B ARHGAP4 AKAP9 SULT1C2 TP53	4.01e-06	689	98	11	36543142
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	INTS1 OBSL1 WDR83 DDX56 YTHDC2 WASHC5 CDC27	5.85e-06	242	98	7	34011540
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DOCK2 MPP2 INTS1 CKAP5 YTHDC2 DDX46 LMO7 CDC27 SNX12 HSP90AB1	5.97e-06	582	98	10	20467437
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	TTC21A POLR2A INTS1 MYOM3 CKAP5 RYR1 POTEE CTNNBL1 PLCB3 RPE65 HSP90AB1	7.47e-06	736	98	11	29676528
Pubmed	Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection.	TERT TP53	7.86e-06	2	98	2	33859071
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEF POTEE	7.86e-06	2	98	2	19669888
Pubmed	Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development.	TERT TP53	7.86e-06	2	98	2	12242304
Pubmed	Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma.	TERF2 TERT	7.86e-06	2	98	2	29043869
Pubmed	p53 Interacts with RNA polymerase II through its core domain and impairs Pol II processivity in vivo.	POLR2A TP53	7.86e-06	2	98	2	21829606
Pubmed	Telomerase Reverse Transcriptase and p53 Regulate Mammalian Peripheral Nervous System and CNS Axon Regeneration Downstream of c-Myc.	TERT TP53	7.86e-06	2	98	2	31597725
Pubmed	DNA damage transiently increases TRF2 mRNA expression and telomerase activity.	TERF2 TERT	7.86e-06	2	98	2	14513051
Pubmed	Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.	TERT TP53	7.86e-06	2	98	2	17433324
Pubmed	Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage.	BCR TP53	7.86e-06	2	98	2	22696202
Pubmed	Molecular and cellular basis of mammary gland fibrosis and cancer risk.	TERF2 TP53	7.86e-06	2	98	2	30450584
Pubmed	Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells.	AQP12A AQP12B	7.86e-06	2	98	2	15809071
Pubmed	Apoptosis promoted by up-regulation of TFPT (TCF3 fusion partner) appears p53 independent, cell type restricted and cell density influenced.	TFPT TP53	7.86e-06	2	98	2	17041757
Pubmed	Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression.	TERT TP53	7.86e-06	2	98	2	22765508
Pubmed	Pancreas-specific aquaporin 12 null mice showed increased susceptibility to caerulein-induced acute pancreatitis.	AQP12A AQP12B	7.86e-06	2	98	2	19726746
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	7.86e-06	2	98	2	9566880
Pubmed	Morphine treatment is associated with diminished telomere length together with down-regulated TERT and TERF2 mRNA levels.	TERF2 TERT	7.86e-06	2	98	2	34482039
Pubmed	Expression of N471D strumpellin leads to defects in the endolysosomal system.	WASHC5 TP53	7.86e-06	2	98	2	30061306
Pubmed	Telomere DNA Damage Signaling Regulates Prostate Cancer Tumorigenesis.	TERF2 TP53	7.86e-06	2	98	2	32467172
Pubmed	Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.	TERT TP53	7.86e-06	2	98	2	16818635
Pubmed	Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer.	TERT TP53	7.86e-06	2	98	2	34028171
Pubmed	TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.	TERT TP53	7.86e-06	2	98	2	34381934
Pubmed	Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury.	SLC22A2 TP53	7.86e-06	2	98	2	28414026
Pubmed	Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma.	TERT TP53	7.86e-06	2	98	2	36926116
Pubmed	p53 regulates Hsp90beta during arsenite-induced cytotoxicity in glutathione-deficient cells.	TP53 HSP90AB1	7.86e-06	2	98	2	18996350
Pubmed	Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.	TERT TP53	7.86e-06	2	98	2	11788906
Pubmed	p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.	LDHA TP53	7.86e-06	2	98	2	30618169
Pubmed	WWP2 ameliorates acute kidney injury by mediating p53 ubiquitylation and degradation.	WWP2 TP53	7.86e-06	2	98	2	32248569
Pubmed	Genetic analysis of the aquaporin water channels AQP12A and AQP12B in patients with chronic pancreatitis.	AQP12A AQP12B	7.86e-06	2	98	2	36167651
Pubmed	Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells.	TP53 HSP90AB1	7.86e-06	2	98	2	15284248
Pubmed	p53-dependent integration of telomere and growth factor deprivation signals.	TERT TP53	7.86e-06	2	98	2	17360541
Pubmed	TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features.	TERT TP53	7.86e-06	2	98	2	34001963
Pubmed	Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells.	POTEE POTEJ	7.86e-06	2	98	2	18447647
Pubmed	Antitumor activity of a pyrrole-imidazole polyamide.	POLR2A TP53	7.86e-06	2	98	2	23319609
Pubmed	Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.	TERT TP53	7.86e-06	2	98	2	16651430
Pubmed	Pulmonary Alveolar Stem Cell Senescence, Apoptosis, and Differentiation by p53-Dependent and -Independent Mechanisms in Telomerase-Deficient Mice.	TERT TP53	7.86e-06	2	98	2	34831112
Pubmed	Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.	MUC16 TP53	7.86e-06	2	98	2	28637689
Pubmed	p53 and hTERT determine sensitivity to viral apoptosis.	TERT TP53	7.86e-06	2	98	2	17855516
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	GALK1 CKAP5 DDX56 YTHDC2 RPL14 TERF2 GRSF1 DDX46 TP53	9.88e-06	486	98	9	30940648
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	POTEF RPL14 ACTR1B DDX46 LMO7 WASHC5 TADA2A POTEI POTEJ	1.36e-05	506	98	9	30890647
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	POLR2A INTS1 MYOM3 GEMIN5 DDX56 NDUFA1 MAST2 BCR RYR1 SLC45A3 PTPRS NEK8 ULK4	1.38e-05	1105	98	13	35748872
Pubmed	A large family of endosome-localized proteins related to sorting nexin 1.	SNX17 SNX13 SNX12	1.43e-05	17	98	3	11485546
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	DNAH10 POTEF MAST2 NEFH PLCB1 HSP90AB1	1.56e-05	187	98	6	26460568
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NET1 POLR2A INTS1 CKAP5 GEMIN5 DDX56 YTHDC2 TERF2 GRSF1 POTEE TFPT DDX46 CTNNBL1 MPHOSPH6 CDC27	1.91e-05	1497	98	15	31527615
Pubmed	Expression of hTERT, p53 and PCNA in cystitis glandularis.	TERT TP53	2.35e-05	3	98	2	17828505
Pubmed	Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.	TERT TP53	2.35e-05	3	98	2	26553052
Pubmed	p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.	TERT TP53	2.35e-05	3	98	2	12496479
Pubmed	Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility.	TERF2 TERT	2.35e-05	3	98	2	19285750
Pubmed	Telomerase reverse transcriptase delays aging in cancer-resistant mice.	TERT TP53	2.35e-05	3	98	2	19013273
Pubmed	Aneuploidy is associated with TP53 expression but not with BRCA1 or TERT expression in sporadic colorectal cancer.	TERT TP53	2.35e-05	3	98	2	20032382
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRS	2.35e-05	3	98	2	20139422
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRS	2.35e-05	3	98	2	33656439
Pubmed	Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation.	TERT TP53	2.35e-05	3	98	2	12508351
Pubmed	Telomeres and chromosomal instability in chronic lymphocytic leukemia.	TERF2 TERT	2.35e-05	3	98	2	22878603
Pubmed	Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice.	BCR TERT	2.35e-05	3	98	2	22408137
Pubmed	A crucial role for adipose tissue p53 in the regulation of insulin resistance.	TERT TP53	2.35e-05	3	98	2	19718037
Pubmed	Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures.	TP53 HSP90AB1	2.35e-05	3	98	2	15358771
Pubmed	DNA damage response inhibition at dysfunctional telomeres by modulation of telomeric DNA damage response RNAs.	TERF2 TP53	2.35e-05	3	98	2	28239143
Pubmed	Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease.	BTN2A1 BTN2A2	2.35e-05	3	98	2	37356345
Pubmed	Phospholipase C in mouse oocytes: characterization of beta and gamma isoforms and their possible involvement in sperm-induced Ca2+ spiking.	PLCB1 PLCB3	2.35e-05	3	98	2	8687404
Pubmed	RANKL-Induced Btn2a2 - A T Cell Immunomodulatory Molecule - During Osteoclast Differentiation Fine-Tunes Bone Resorption.	BTN2A1 BTN2A2	2.35e-05	3	98	2	34421818
Pubmed	Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.	TERT TP53	2.35e-05	3	98	2	15545228
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRS	2.35e-05	3	98	2	9784606
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	2.35e-05	3	98	2	25394468
Pubmed	Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.	TERT TP53	2.35e-05	3	98	2	18843043
Pubmed	Tubal metaplasia of the endometrium with cytologic atypia: analysis of p53, Ki-67, TERT, and long-term follow-up.	TERT TP53	2.35e-05	3	98	2	21572399
Pubmed	SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.	TERF2 TP53	2.35e-05	3	98	2	34232992
Pubmed	Knocking down p53 with siRNA does not affect the overexpression of p21WAF-1 after exposure of IMR-90 hTERT fibroblasts to a sublethal concentration of H2O2 leading to premature senescence.	TERT TP53	2.35e-05	3	98	2	17460194
Pubmed	Effect of HSP90AB1 and CC domain interaction on Bcr-Abl protein cytoplasm localization and function in chronic myeloid leukemia cells.	BCR HSP90AB1	2.35e-05	3	98	2	34217296
Pubmed	Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.	TERF2 TERT	2.35e-05	3	98	2	17681636
Pubmed	Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells.	WWP2 POLR2A	2.35e-05	3	98	2	17526739
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRS	2.35e-05	3	98	2	31985401
Pubmed	Cell cycle control of telomere protection and NHEJ revealed by a ts mutation in the DNA-binding domain of TRF2.	TERF2 TP53	2.35e-05	3	98	2	18451109
Pubmed	The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.	TERT TP53	2.35e-05	3	98	2	17974918
Pubmed	Dysfunctional mammalian telomeres join with DNA double-strand breaks.	TERF2 TP53	2.35e-05	3	98	2	15010310
Pubmed	Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.	TERT TP53	2.35e-05	3	98	2	21042751
Pubmed	MYC amplification and TERT expression in breast tumor progression.	TERT TP53	2.35e-05	3	98	2	17656250
Pubmed	PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells.	TERT TP53	2.35e-05	3	98	2	24412852
Pubmed	Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.	TERF2 TP53	2.35e-05	3	98	2	18056407
Pubmed	[Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia].	TERT TP53	2.35e-05	3	98	2	12452037
Pubmed	Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.	TERT TP53	2.35e-05	3	98	2	28627647
Pubmed	Telomeric repeat-containing RNA (TERRA) and telomerase are components of telomeres during mammalian gametogenesis.	TERF2 TERT	2.35e-05	3	98	2	24719256
Pubmed	Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.	TERT TP53	2.35e-05	3	98	2	23106581
Pubmed	Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts.	TERT TP53	2.35e-05	3	98	2	14743210
Pubmed	Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.	MUC16 TP53	2.35e-05	3	98	2	36271032
Pubmed	Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.	BCR TP53	2.35e-05	3	98	2	18227349
Pubmed	A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice.	TERT TP53	2.35e-05	3	98	2	18626023
Pubmed	Telomerase rescues the expression levels of keratinocyte growth factor and insulin-like growth factor-II in senescent human fibroblasts.	TERT FGF7	2.35e-05	3	98	2	12243757
Interaction	PTGES3 interactions	MPP2 POLR2A GEMIN5 YTHDC2 RPL14 BCR TERF2 TERT NEK8 FRMD5 TP53 HSP90AB1	1.12e-06	437	96	12	int:PTGES3
Interaction	CDC5L interactions	MPP2 WWP2 POLR2A INTS1 CKAP5 OBSL1 WDR83 DDX46 AKAP9 LMO7 CTNNBL1 TADA2A CDC27 SNX12 CCDC136 HSP90AB1	2.63e-06	855	96	16	int:CDC5L
Interaction	SCIN interactions	POTEF CKAP5 OBSL1 ACTR1B POTEI	8.29e-06	58	96	5	int:SCIN
Interaction	CAP2 interactions	POTEF POTEI POTEJ TP53 HSP90AB1	1.57e-05	66	96	5	int:CAP2
Interaction	SEZ6L interactions	SNX17 PTPRD PTPRS	1.68e-05	11	96	3	int:SEZ6L
Interaction	SSX5 interactions	AKAP9 NFE2 TP53	1.68e-05	11	96	3	int:SSX5
Interaction	PARD6G interactions	WDR83 BRINP1 AKAP9 PNMA3	2.01e-05	34	96	4	int:PARD6G
Interaction	PFDN2 interactions	POTEF WWP2 POLR2A POTEE WRAP73 POTEI POTEJ HSP90AB1	2.38e-05	247	96	8	int:PFDN2
Interaction	DCTN2 interactions	DNAH10 POLR2A CKAP5 BCR ACTR1B AKAP9 CTNNBL1 TP53 HSP90AB1	5.08e-05	356	96	9	int:DCTN2
Interaction	CCT6B interactions	WWP2 OXCT2 WDR83 LDHA ACTR1B RPE65 TP53	6.00e-05	207	96	7	int:CCT6B
Interaction	SNRPD3 interactions	WWP2 POLR2A CKAP5 OBSL1 WDR83 GEMIN5 RPL14 DDX46 TP53	8.38e-05	380	96	9	int:SNRPD3
Interaction	ACTG2 interactions	POTEF POTEE POTEI POTEJ	8.69e-05	49	96	4	int:ACTG2
Interaction	CEP128 interactions	POLR2A CKAP5 WDR83 BCR LMO7 WASHC5 WRAP73 TP53	8.74e-05	297	96	8	int:CEP128
Cytoband	2q21.1	POTEF POTEE POTEI POTEJ	7.58e-06	58	98	4	2q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr2q21	POTEF POTEE POTEI POTEJ	3.20e-04	151	98	4	chr2q21
Cytoband	Ensembl 112 genes in cytogenetic band chr16q22	WWP2 TERF2 COG8 TXNL4B	6.59e-04	183	98	4	chr16q22
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEF POTEE POTEI POTEJ	1.80e-07	13	74	4	685
GeneFamily	Fibronectin type III domain containing	IGFN1 MYOM3 PTPRD PTPRO PTPRS EPHB1	4.93e-05	160	74	6	555
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRO PTPRS	8.30e-05	21	74	3	813
GeneFamily	Sorting nexins\|PX-BAR domain containing	SNX17 SNX13 SNX12	2.23e-04	29	74	3	754
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGFN1 MYOM3 OBSL1 PTPRD PTPRS	5.17e-04	161	74	5	593
GeneFamily	Phospholipases	PLCB1 PLD6 PLCB3	6.74e-04	42	74	3	467
GeneFamily	Paraneoplastic Ma antigens	MOAP1 PNMA3	8.87e-04	11	74	2	671
GeneFamily	Aquaporins	AQP12A AQP12B	1.46e-03	14	74	2	305
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN2A1 BTN2A2	1.68e-03	15	74	2	458
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCB1 PLCB3	2.70e-03	19	74	2	832
GeneFamily	PDZ domain containing	MPP2 MAST2 LIN7B LMO7	3.50e-03	152	74	4	1220
ToppCell	343B-Fibroblasts-Fibroblast-H\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IQCH PDE1B TTC21A TXNL4B WRAP73 HAS2	2.25e-06	172	98	6	eb199c279fe8a2551121db37e9556893197d33ff
ToppCell	343B-Fibroblasts-Fibroblast-H-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IQCH PDE1B TTC21A TXNL4B WRAP73 HAS2	2.25e-06	172	98	6	709c6b77a7a52b873eefb6caca28a41291d384af
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 FREM1 PTPRD PTPRS FGF7 HAS2	4.50e-06	194	98	6	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT3 BRINP1 PTPRD PLCB1 CCDC136 FRMD5	4.64e-06	195	98	6	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IQCH DNAH10 TTC21A AKAP9 EFCAB12 ULK4	4.92e-06	197	98	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DNAH10 OBSL1 POTEE NFE2 HAS2	8.77e-06	126	98	5	10e1448a03f79965b72922fd83ef51de1b7b474f
ToppCell	TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11\|TCGA-Brain / Sample_Type by Project: Shred V9	POTEF POTEE POTEI POTEJ	1.14e-05	63	98	4	d7dc1356a60cb527fe668328d5375f352239d911
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	MUC16 RYR1 LIN7B PTPRS EPHB1	2.86e-05	161	98	5	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FAT3 PCDHB15 FREM1 PTPRD NEK8	3.31e-05	166	98	5	65dafed953b01a9830b54309af75c7a561e88336
ToppCell	FLU-Healthy-3\|FLU / Virus stimulation, Condition and Cluster	IQCH OXCT2 MAST2 LMO7 CCDC136	4.03e-05	173	98	5	32b8e5b400885dbeba57a7cb2c18d882664dc285
ToppCell	FLU-Healthy-3\|Healthy / Virus stimulation, Condition and Cluster	IQCH OXCT2 MAST2 LMO7 CCDC136	4.03e-05	173	98	5	26e89ac86922f1cd0100cf4d1cce37e74dd31c88
ToppCell	343B-Fibroblasts-Fibroblast-H-\|343B / Donor, Lineage, Cell class and subclass (all cells)	IQCH FREM1 SCARA5 FGF7 HAS2	4.15e-05	174	98	5	2627c3983009839fedbc5e3f628739dc026447f4
ToppCell	343B-Fibroblasts-Fibroblast-H\|343B / Donor, Lineage, Cell class and subclass (all cells)	IQCH FREM1 SCARA5 FGF7 HAS2	4.15e-05	174	98	5	507a33e58f62e2b72f0bcc743e84dbd0bf705a15
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NET1 LIN7B SCARA5 GOLGA7B FRMD5	4.50e-05	177	98	5	7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad
ToppCell	myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell\|myeloid / Lineage, cell class and subclass	PTPRS SCARA5 NEK8 STAMBPL1 EPHB1	4.62e-05	178	98	5	f75591988bbbeba073b66329a3437cb9b02f7648
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9\|TCGA-Breast / Sample_Type by Project: Shred V9	POTEF POTEE POTEI POTEJ	4.68e-05	90	98	4	96e836c7a1df279ac812b7c3aa75e6b81b614244
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 DNAH10 FAT3 FREM1 PTPRD	5.41e-05	184	98	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 DNAH10 FAT3 FREM1 PTPRD	5.41e-05	184	98	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 DNAH10 FAT3 FREM1 PTPRD	5.41e-05	184	98	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COG8 SCARA5 ULK4 FGF7 HAS2	5.69e-05	186	98	5	f07e0c0d9c80ac9d8d679950e7d0c812becb85a3
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	IGFN1 FREM1 PTPRS FGF7 HAS2	5.84e-05	187	98	5	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 FREM1 PTPRD FGF7 HAS2	6.14e-05	189	98	5	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	HSPCs-Ery_prog.\|HSPCs / Lineage and Cell class	GALK1 RPL14 NEFH SLC45A3 TP53	6.14e-05	189	98	5	37d2c45debed1564a40a1085b8b310c50923b9e7
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 FREM1 PTPRD PTPRS FGF7	6.14e-05	189	98	5	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FAT3 BRINP1 FREM1 PTPRD PTPRS	6.30e-05	190	98	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 FREM1 PTPRD FGF7 HAS2	6.45e-05	191	98	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FAT3 BRINP1 FREM1 PTPRD FGF7	6.45e-05	191	98	5	a05e9a7eb137d804570dd7d8905975d735738767
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	6.61e-05	192	98	5	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 FREM1 PTPRD FGF7 HAS2	6.61e-05	192	98	5	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	6.61e-05	192	98	5	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FAT3 BRINP1 FREM1 PTPRD FGF7	6.61e-05	192	98	5	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OBSL1 AKAP9 SULT1C2 SLC22A2 PLCB1	6.61e-05	192	98	5	ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	6.78e-05	193	98	5	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	6.78e-05	193	98	5	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	FAT3 FREM1 PTPRD PTPRS FGF7	6.78e-05	193	98	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 FREM1 PTPRD PTPRS FGF7	6.95e-05	194	98	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RPL14 FREM1 NEFH CTNNBL1 HSP90AB1	6.95e-05	194	98	5	7ad255fa357d41fe57ed803314de46a6577a1283
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 FREM1 PTPRD FGF7 HAS2	6.95e-05	194	98	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 TTC21A MUC16 EFCAB12 ULK4	6.95e-05	194	98	5	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MPP2 PTPRS SCARA5 PLCB1 FGF7	7.12e-05	195	98	5	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	7.12e-05	195	98	5	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	7.12e-05	195	98	5	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	7.12e-05	195	98	5	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	7.12e-05	195	98	5	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	7.12e-05	195	98	5	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT3 BRINP1 FREM1 PTPRD FGF7	7.12e-05	195	98	5	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT3 PTPRD PTPRS FGF7 HAS2	7.29e-05	196	98	5	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT3 FREM1 PTPRS SCARA5 FGF7	7.29e-05	196	98	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT3 PTPRD PTPRS FGF7 HAS2	7.29e-05	196	98	5	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FREM1 PTPRD SLC45A3 FGF7 HAS2	7.47e-05	197	98	5	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGFN1 PTPRD PTPRS FGF7 HAS2	7.47e-05	197	98	5	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OBSL1 PTPRD PTPRS SCARA5 FGF7	7.47e-05	197	98	5	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OBSL1 AKAP9 SULT1C2 SLC22A2 PLCB1	7.47e-05	197	98	5	4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OBSL1 PTPRD PTPRS SCARA5 FGF7	7.47e-05	197	98	5	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OBSL1 PTPRD PTPRS SCARA5 FGF7	7.47e-05	197	98	5	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MPP2 NET1 FAT3 TERT CCDC136	7.65e-05	198	98	5	d1827e3707b929e3a3562989a0c11537d344e164
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 EFCAB12 SLC22A2 RPE65 FRMD5	7.83e-05	199	98	5	92778939e9d06599c7d06cfd8f4362b97ed0606b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	RPL14 PTPRD AKAP9 LMO7 HSP90AB1	7.83e-05	199	98	5	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	DDX56 WRAP73 CDK5RAP1 STAMBPL1 FRMD5	7.83e-05	199	98	5	cdcdef1d95a8e476de016b1e11ee010438834be0
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	RPL14 PTPRD AKAP9 LMO7 HSP90AB1	7.83e-05	199	98	5	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FAT3 FREM1 PTPRD FGF7 HAS2	7.83e-05	199	98	5	6bce8e65859a35cfea1c210f9c9765952d492ed2
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FREM1 PTPRD AKAP9 FGF7 HAS2	8.02e-05	200	98	5	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	FAT3 PTPRD PTPRO PLCB1 EPHB1	8.02e-05	200	98	5	7bba2ff09349c8db3d1ccf53520b12cbf7b0abac
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT3 FREM1 PTPRS SCARA5 FGF7	8.02e-05	200	98	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT3 FREM1 PTPRS SCARA5 FGF7	8.02e-05	200	98	5	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	FREM1 PTPRD AKAP9 FGF7 HAS2	8.02e-05	200	98	5	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	IQCH KLHDC7B TERT	2.05e-04	52	98	3	106dd69be38d8ebd298d825c14ac0eefd8366a1a
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	IQCH KLHDC7B TERT	2.05e-04	52	98	3	9eaf9c1276a3e074cf6c476a419546cbbe4d525c
Drug	pentoxifylline	ENPP7 PDE1B SNX17 LDHA SNX13 ACTR1B PLCB1 PLD6 PLCB3 SNX12	7.01e-07	304	97	10	CID000004740
Disease	Myeloproliferative disease	BCR TERT TP53	5.53e-06	12	88	3	C0027022
Disease	squamous cell carcinoma (is_marker_for)	FGF7 RPE65 TP53	2.40e-05	19	88	3	DOID:1749 (is_marker_for)
Disease	myelodysplastic syndrome (is_marker_for)	TERT PLCB1 TP53	2.82e-05	20	88	3	DOID:0050908 (is_marker_for)
Disease	central nervous system cancer	POLR2A TERT TP53	1.08e-04	31	88	3	EFO_0000326
Disease	very low density lipoprotein cholesterol measurement	DNAH10 SNX17 DDX56 TXNL4B SLC22A2 PLCB3	1.31e-04	260	88	6	EFO_0008317
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	MPP2 DNAH10 DDX56 SNX13 SLC22A2 PLCB3	1.42e-04	264	88	6	EFO_0008317, EFO_0020944
Disease	Parkinson disease, disease progression measurement	SNX13 PTPRD SULT1C2	2.17e-04	39	88	3	EFO_0008336, MONDO_0005180
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DNAH10 DDX56 SNX13 TXNL4B SLC22A2 PLCB3	2.41e-04	291	88	6	EFO_0008317, EFO_0020946
Disease	basal cell carcinoma (is_marker_for)	RPE65 TP53	2.43e-04	8	88	2	DOID:2513 (is_marker_for)
Disease	age at onset, glioblastoma multiforme	TERT TP53	2.43e-04	8	88	2	EFO_0000519, EFO_0004847
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	SNX13 SLC45A3 PLCB3 EPHB1	2.61e-04	103	88	4	EFO_0008595, EFO_0020944
Disease	uterine fibroid, Menorrhagia	TERT TP53	3.12e-04	9	88	2	EFO_0000731, HP_0000132
Disease	glioblastoma multiforme	TERT TP53	3.12e-04	9	88	2	EFO_0000519
Disease	total lipids in small LDL	SNX17 TXNL4B SLC22A2	3.78e-04	47	88	3	EFO_0022168
Disease	free cholesterol in medium VLDL measurement	SNX17 TXNL4B SLC22A2	3.78e-04	47	88	3	EFO_0022269
Disease	triple-negative breast cancer	TERT TP53	3.90e-04	10	88	2	EFO_0005537
Disease	Uterine leiomyoma, estrogen-receptor negative breast cancer	TERT TP53	3.90e-04	10	88	2	EFO_1000650, HP_0000131
Disease	acute myeloid leukemia (is_marker_for)	TERT PLCB1 TP53	4.28e-04	49	88	3	DOID:9119 (is_marker_for)
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	DNAH10 DDX56 TXNL4B SLC22A2 PLCB3	4.70e-04	215	88	5	EFO_0008317, EFO_0008591
Disease	phospholipids in medium VLDL measurement	SNX17 TXNL4B SLC22A2	5.10e-04	52	88	3	EFO_0022154
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 DDX56 TXNL4B SLC22A2 PLCB3	5.22e-04	220	88	5	EFO_0004529, EFO_0008317
Disease	cholesterol in small VLDL measurement	SNX17 TXNL4B SLC22A2	5.39e-04	53	88	3	EFO_0022228
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	DNAH10 DDX56 TXNL4B SLC22A2 PLCB3	6.26e-04	229	88	5	EFO_0004639, EFO_0008317
Disease	Modic type vertebral endplate changes	MPP2 PTPRD	6.71e-04	13	88	2	HP_0030775
Disease	very low density lipoprotein particle size measurement	MPP2 TXNL4B SLC22A2 PLCB3	6.86e-04	133	88	4	EFO_0008594
Disease	serum non-albumin protein measurement	POLR2A MAST2 TERT TXNL4B ULK4 TP53	7.50e-04	361	88	6	EFO_0004568
Disease	phospholipids in small VLDL measurement	SNX17 TXNL4B SLC22A2	7.76e-04	60	88	3	EFO_0022146
Disease	lobe size	SULT1C2 EPHB1	7.82e-04	14	88	2	EFO_0007666
Disease	central nervous system cancer, glioblastoma multiforme	TERT TP53	7.82e-04	14	88	2	EFO_0000326, EFO_0000519
Disease	Adenocarcinoma Of Esophagus	DOCK2 TP53	7.82e-04	14	88	2	C0279628
Disease	unipolar depression, anxiety	BRINP1 PTPRD	7.82e-04	14	88	2	EFO_0003761, EFO_0005230
Disease	apolipoprotein B measurement	GALK1 DNAH10 SNX17 DDX56 TXNL4B SLC22A2 PLCB3 TP53	8.26e-04	663	88	8	EFO_0004615
Disease	triglyceride measurement, phospholipid measurement	DNAH10 SNX13 SLC22A2 PLCB3	9.72e-04	146	88	4	EFO_0004530, EFO_0004639
Disease	cholesterol in large VLDL measurement	DNAH10 TXNL4B SLC22A2	9.80e-04	65	88	3	EFO_0021902
Disease	total lipids in small VLDL	DNAH10 TXNL4B SLC22A2	1.07e-03	67	88	3	EFO_0022148
Disease	reticulocyte count	DNAH10 POTEF SNX17 GEMIN5 MAST2 NFE2 NEK8 PLCB1 PLCB3 HSP90AB1	1.10e-03	1045	88	10	EFO_0007986
Disease	Colorectal Carcinoma	BRINP1 NDUFA1 PTPRD AKAP9 LMO7 PTPRS PIGO TP53	1.19e-03	702	88	8	C0009402
Disease	Uterine leiomyoma, estrogen-receptor positive breast cancer	TERT TP53	1.30e-03	18	88	2	EFO_1000649, HP_0000131
Disease	Adrenocortical carcinoma	TERT TP53	1.30e-03	18	88	2	C0206686
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	SNX17 SULT1C2 TXNL4B SLC22A2 PLCB3	1.39e-03	274	88	5	EFO_0004530, EFO_0004612
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	DNAH10 TXNL4B SLC22A2 PLCB3	1.56e-03	166	88	4	EFO_0004530, EFO_0004611
Disease	mean corpuscular hemoglobin concentration	POTEF POLR2A TERT SNX13 NFE2 PLCB1 PLCB3 PIGO TP53 HSP90AB1	1.67e-03	1105	88	10	EFO_0004528
Disease	sexual dimorphism measurement	MPP2 DNAH10 POLR2A BTN2A1 SNX13 BTN2A2 CDK5RAP1 ULK4 PLCB3 TP53	1.68e-03	1106	88	10	EFO_0021796
Disease	Precursor B-cell lymphoblastic leukemia	BCR TP53	1.78e-03	21	88	2	C1292769
Disease	pulmonary hypertension (biomarker_via_orthology)	TERT RYR1 HAS2	1.78e-03	80	88	3	DOID:6432 (biomarker_via_orthology)
Disease	cervical squamous cell carcinoma (is_marker_for)	FGF7 TP53	1.95e-03	22	88	2	DOID:3744 (is_marker_for)
Disease	glioma	TERT TP53	1.95e-03	22	88	2	EFO_0005543
Disease	triacylglycerol 48:2 measurement	SNX17 MPHOSPH6	1.95e-03	22	88	2	EFO_0010405
Disease	triacylglycerol 48:3 measurement	SNX17 MPHOSPH6	1.95e-03	22	88	2	EFO_0010406
Disease	serum albumin measurement	SNX17 TERT SNX13 TXNL4B CDK5RAP1 FRMD5 TP53	1.97e-03	592	88	7	EFO_0004535
Disease	Kidney Diseases	TERT NEK8 SLC22A2	2.34e-03	88	88	3	C0022658
Disease	prostate specific antigen measurement	TERT SLC45A3 CDK5RAP1 TP53	2.45e-03	188	88	4	EFO_0004624
Disease	cardiovascular disease	MPP2 DDX56 TERF2 FREM1 TXNL4B PLCB1	2.48e-03	457	88	6	EFO_0000319
Disease	response to TNF antagonist, joint damage measurement	MPP2 BRINP1	2.52e-03	25	88	2	EFO_0004653, EFO_0005413
Disease	sleep duration, low density lipoprotein cholesterol measurement	DDX56 SNX13 TXNL4B	2.58e-03	91	88	3	EFO_0004611, EFO_0005271
Disease	L lactate dehydrogenase measurement	LDHA SNX13	2.73e-03	26	88	2	EFO_0004808
Disease	pulse pressure measurement	IQCH FAT3 WWP2 CKAP5 MAST2 TERF2 PTPRD SLC22A2 ULK4 STAMBPL1 TP53	2.83e-03	1392	88	11	EFO_0005763
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 SLC22A2 PLCB3	2.91e-03	95	88	3	EFO_0004529, EFO_0008317, EFO_0008596
Disease	chronic myeloid leukemia (is_marker_for)	BCR TERT	2.94e-03	27	88	2	DOID:8552 (is_marker_for)
Disease	azoospermia (implicated_via_orthology)	PTPRD PTPRS	2.94e-03	27	88	2	DOID:14227 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
RELEEMRVTYGTEGL	AKAP9	176	Q99996
VGAYEVFAREAMRTL	AQP12A	31	Q8IXF9
RERGRYREEEMTVVE	CTNNBL1	36	Q8WYA6
YFVDRDGTMRRLHEI	BRINP1	171	O60477
EEIERRGMEEVGIYR	BCR	1076	P11274
MRVDIAGRDVSRYLR	ACTR1B	181	P42025
VGAYEVFAREAMRTL	AQP12B	31	A6NM10
TLEEMEEVGKRYRER	EFCAB12	326	Q6NXP0
RMRDVVGYFSIDLVT	IQCH	811	Q86VS3
VDITFVMDYRGRRKT	GRSF1	276	Q12849
DSARFRYLMGERLGV	LDHA	166	P00338
REIRRQEAIYEMSRG	NET1	171	Q7Z628
DDGIYLCEMRGRVRT	OBSL1	406	O75147
GAHRIYTEMRFTVRD	EPHB1	81	P54762
RVDRVAIYEEFLRMT	MUC16	14401	Q8WXI7
HGYRFTTMAEREIVR	POTEF	896	A5A3E0
ERVRKRGFEVVYMTE	HSP90AB1	501	P08238
VRYTPRVLEEMEARF	LIN7B	171	Q9HAP6
RYVRRMRQSKEGEEV	INTS1	1126	Q8N201
ERGMRVIEISIYEDR	GOLGA7B	126	Q2TAP0
EEIEGFRYRCRDAMR	DDX56	421	Q9NY93
LGEYRLLGRMFRRDE	MOAP1	46	Q96BY2
RILITVYRMSEAEGR	OR2T7	211	P0C7T2
AGIFVERMFRRTYTS	PDE1B	131	Q01064
LEIIRRGYSMDSAFV	FREM1	1761	Q5H8C1
RRGDYRAFGRLMVES	GALK1	296	P51570
LRVIGYLRRMDVFTE	COG8	226	Q96MW5
MEKYERIRVVGRGAF	NEK8	1	Q86SG6
RRMYSFDDVLEEGKR	LMO7	801	Q8WWI1
VSRGEMEADVRAGRY	MPP2	426	Q14168
EYFTLQIRGRERFEM	TP53	326	P04637
RRYSVMEETERGSFV	PCDHB15	31	Q9Y5E8
FVDILGLVSEMRSYR	PTPRO	1161	Q16827
VLERMRYEGVVDIFQ	PTPRS	1896	Q13332
RGYRFTTMAEREIVR	POTEE	896	Q6S8J3
RGVITMNEEYETRFL	PTPMT1	66	Q8WUK0
YVEVDMFGLPVDTRR	PLCB3	746	Q01970
YEREVREMRGAVLRL	NEFH	146	P12036
RFRYSGRVAKEVMES	FRMD5	316	Q7Z6J6
AYMRIFGVLAVDTLR	EFCAB5	1111	A4FU69
FQSYVERGLRVIEME	CKAP5	1876	Q14008
EYGVREMPDFDDRRV	DOCK2	1616	Q92608
MTVEYRASVRADVGR	FAT3	2601	Q8TDW7
REVMYTAFRALGRSV	HAS2	191	Q92819
GRERTEEQMEEYRGR	BTN2A1	81	Q7KYR7
FTLRAIRVYMGDSDV	MAST2	1116	Q6P0Q8
YRFDLLRGVGAAVMR	KLHDC7B	496	Q96G42
YGIVDYRGMLRRLQE	IGFN1	186	Q86VF2
RRVTYVVLDEADRMF	DDX46	521	Q7L014
ERREMVRQVDRTVGY	ENPP7	211	Q6UWV6
YDYMEGGDIRVRRLF	FGF7	56	P21781
RERTEEQMEEYRGRI	BTN2A2	86	Q8WVV5
EVMYGGRAIDSFDRR	DNAH10	4086	Q8IVF4
CRMLGFRGVEEVYRT	SCARA5	431	Q6ZMJ2
AFMIILTIDRIGRRY	SLC22A2	391	O15244
YLGRIEIMGASRRIE	RYR1	4176	P21817
EIMGASRRIERIYFE	RYR1	4181	P21817
RRIENYRVEGMEIYS	CDC27	526	P30260
MIGVRELRDAFREFD	CABP2	151	Q9NPB3
SLMERDRRISGVDRY	NDUFA1	46	O15239
LERMRYEGVVDIFQT	PTPRD	1861	P23468
EGTEAGRRRSEYVEM	NFE2	161	Q16621
RGVRVRVVTDCDYMA	PLD6	116	Q8N2A8
RRMVYVFLEGFLETL	SNX13	916	Q9Y5W8
RRFIRTDAYVRAMTE	RPE65	81	Q16518
GVGRARFTTYEVRMR	SNX12	41	Q9UMY4
YETMRRFARIVGPVE	TADA2A	251	O75478
DEEMARRYETLVGTI	MPHOSPH6	111	Q99547
LGRYRVIGRMFRREE	PNMA3	46	Q9UL41
LTERGYRFTTMAERE	POTEJ	856	P0CG39
YRFTTMAEREIVRDI	POTEJ	861	P0CG39
RGYRFTTMAEREIVR	POTEI	896	P0CG38
FTRDGRYMALAERRD	WRAP73	141	Q9P2S5
RAIEIYTDMGRFTIA	NAPA	106	P54920
RIIRRAALEFEDGMY	OXCT2	301	Q9BYC2
EFMRRRAEVELEYSR	ARHGAP4	51	P98171
VMDRLVQRFGTRAVY	SLC45A3	341	Q96JT2
ERIRGDYEMEIASLR	CCDC136	186	Q96JN2
EAMRRGYSREAYVEL	CDK5RAP1	411	Q96SZ6
RGEVRLELAFEYLMS	SNX17	341	Q15036
LSRASFGYMRLVVRE	PHETA2	116	Q6ICB4
RRRLYIIMRGEEGLD	WWP2	541	O00308
FISMVIGRLRSDDIY	WASHC5	221	Q12768
ERRFLMRVLDSYGDD	TFPT	116	P0C1Z6
MVFRRFVEVGRVAYV	RPL14	1	P50914
RFDEIYRRKMEGTSI	SULT1C2	276	O00338
ITPRRYFRSGVEMER	STAMBPL1	46	Q96FJ0
FERMREDREVLRVIF	POLR2A	956	P24928
FTDRATLYRMIDIEG	GEMIN5	896	Q8TEQ6
TVASIRELMEERYGE	TET3	851	O43151
EYIDRMLKISRGFRE	TTC21A	131	Q8NDW8
VDGRVRRYDLRMGQL	WDR83	171	Q9BRX9
YVEVDMFGLPVDTRR	PLCB1	696	Q9NQ66
IALERFRYGDQREME	YTHDC2	51	Q9H6S0
YRHMQEEFRGRLERT	PIGO	801	Q8TEQ8
MGARETRRLLERVVY	TTC37	1496	Q6PGP7
DFIDLIEVIYRGAMR	TXNL4B	111	Q9NX01
RGSRYGDFRQIRDIM	TERF2	111	Q15554
MDYVVGARTFRREKR	TERT	636	O14746
YTVLMRCLREGEERV	ULK4	606	Q96C45
TFLDRYRMEVRGTEV	MYOM3	1376	Q5VTT5